LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $906,769 | -16.9% | 15,133 | 0.0% | 0.32% | -15.7% |
| Q2 2023 | $1,091,089 | -4.5% | 15,133 | -2.6% | 0.38% | -7.7% |
| Q1 2023 | $1,142,607 | +10.1% | 15,533 | 0.0% | 0.41% | +10.1% |
| Q4 2022 | $1,037,605 | -22.5% | 15,533 | 0.0% | 0.38% | -30.1% |
| Q3 2022 | $1,338,000 | -4.7% | 15,533 | -1.3% | 0.54% | +1.3% |
| Q2 2022 | $1,404,000 | -20.7% | 15,733 | 0.0% | 0.53% | -7.0% |
| Q1 2022 | $1,770,000 | -27.2% | 15,733 | 0.0% | 0.57% | -14.6% |
| Q4 2021 | $2,430,000 | +10.9% | 15,733 | 0.0% | 0.67% | +3.2% |
| Q3 2021 | $2,192,000 | +5.4% | 15,733 | -0.7% | 0.65% | +6.9% |
| Q2 2021 | $2,079,000 | -14.5% | 15,848 | -0.6% | 0.61% | -19.6% |
| Q1 2021 | $2,431,000 | +50.4% | 15,948 | -1.8% | 0.75% | +39.6% |
| Q4 2020 | $1,616,000 | +3.7% | 16,248 | -0.6% | 0.54% | -7.2% |
| Q3 2020 | $1,558,000 | -8.5% | 16,348 | +7.4% | 0.58% | -12.2% |
| Q2 2020 | $1,702,000 | +52.2% | 15,220 | -1.0% | 0.66% | +32.3% |
| Q1 2020 | $1,118,000 | -30.6% | 15,370 | -0.5% | 0.50% | -13.6% |
| Q4 2019 | $1,610,000 | +4.7% | 15,440 | 0.0% | 0.58% | -2.7% |
| Q3 2019 | $1,537,000 | -13.6% | 15,440 | -0.9% | 0.60% | -14.9% |
| Q2 2019 | $1,778,000 | -54.8% | 15,575 | -50.2% | 0.70% | -11.9% |
| Q1 2019 | $3,934,000 | +85.2% | 31,300 | +100.0% | 0.80% | -17.9% |
| Q4 2018 | $2,124,000 | -49.7% | 15,650 | +1.7% | 0.97% | -39.6% |
| Q3 2018 | $4,224,000 | +12.5% | 15,390 | -15.0% | 1.60% | +3.0% |
| Q2 2018 | $3,753,000 | +16.3% | 18,115 | -7.3% | 1.56% | +15.3% |
| Q1 2018 | $3,227,000 | -99.9% | 19,539 | -50.9% | 1.35% | +19.8% |
| Q4 2017 | $2,729,551,000 | +92270.6% | 39,828 | +83.5% | 1.13% | -14.4% |
| Q3 2017 | $2,955,000 | +11.4% | 21,704 | -0.6% | 1.32% | +4.5% |
| Q2 2017 | $2,652,000 | +14.6% | 21,844 | -0.1% | 1.26% | +10.7% |
| Q1 2017 | $2,315,000 | +4.7% | 21,869 | +0.5% | 1.14% | -1.2% |
| Q4 2016 | $2,212,000 | +1.7% | 21,769 | +2.1% | 1.15% | -4.9% |
| Q3 2016 | $2,176,000 | -12.1% | 21,319 | +2.7% | 1.21% | -15.6% |
| Q2 2016 | $2,475,000 | +11.4% | 20,749 | 0.0% | 1.43% | +4.4% |
| Q1 2016 | $2,222,000 | +0.2% | 20,749 | +1.5% | 1.37% | -3.2% |
| Q4 2015 | $2,217,000 | +26.6% | 20,449 | 0.0% | 1.42% | +17.4% |
| Q3 2015 | $1,751,000 | -16.2% | 20,449 | -1.2% | 1.21% | -9.2% |
| Q2 2015 | $2,089,000 | +30.9% | 20,699 | 0.0% | 1.33% | +31.2% |
| Q1 2015 | $1,596,000 | +45.0% | 20,699 | 0.0% | 1.02% | +42.4% |
| Q4 2014 | $1,101,000 | +29.1% | 20,699 | +14.1% | 0.71% | +22.7% |
| Q3 2014 | $853,000 | -24.6% | 18,149 | 0.0% | 0.58% | -25.8% |
| Q2 2014 | $1,131,000 | -25.1% | 18,149 | -19.2% | 0.78% | -28.6% |
| Q1 2014 | $1,510,000 | +30.1% | 22,449 | +1.7% | 1.10% | +23.6% |
| Q4 2013 | $1,161,000 | – | 22,065 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |